Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Phase 1 study in early development stage with no results yet reported; designed to assess safety, tolerability, and dose-finding in a small patient population with EGFR-mutant NSCLC and HNSCC.
This is a registry record for an active observational study with no results posted; it describes planned enrollment and methods only, without outcome data.